Jaguar Health (JAGX) Other Operating Expenses (2015 - 2026)
Jaguar Health (JAGX) reported Other Operating Expenses of $2.1 million for Q1 2026, down 31.72% year-over-year from $3.0 million in Q1 2025, and down 61.08% quarter-over-quarter from $5.3 million in Q4 2025.
Jaguar Health (JAGX) Other Operating Expenses (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Other Operating Expenses data on file, last reported at $2.1 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $2.1 million, down 31.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (up 19.23% YoY), and the FY2025 annual result was $13.8 million, up 43.14% from the prior year.
- Other Operating Expenses fell to $2.1 million in Q1 2026 per JAGX's latest filing, from $5.3 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $5.3 million in Q4 2025 and troughed at $1.9 million in Q1 2024.
- A 5-year average of $2.7 million and a median of $2.6 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2023 and 2025: Other Operating Expenses sank 32.25% in 2023, then surged 61.31% in 2025.
- A 5-year view of Other Operating Expenses shows it stood at $2.2 million in 2022, then advanced by 15.43% to $2.6 million in 2023, then increased by 26.38% to $3.3 million in 2024, then surged by 61.31% to $5.3 million in 2025, then plunged by 61.08% to $2.1 million in 2026.
- Business Quant data shows JAGX's Other Operating Expenses at $2.1 million in Q1 2026, $5.3 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 5.28 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 2.99 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | 2.55 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | 1.99 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | 2.23 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Sep 30, 2022 | 2.72 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 3.29 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Sep 30, 2021 | 2.88 Mn |
| Jun 30, 2021 | 3.03 Mn |